Rachel Park advises life sciences, medical device, pharmaceutical, and biotech clients on FDA and healthcare regulatory matters.
Prior to joining Morrison & Foerster, Rachel was an associate at an international law firm where she counseled clients on FDA and healthcare regulatory matters. She has counseled pharmaceutical and medical device clients on product promotion, Sunshine Act reporting requirements, and internal compliance investigations. Rachel has helped various healthcare clients analyze state corporate practice of medicine and fee-splitting prohibitions and state licensing requirements.
Rachel received her J.D. from the George Washington University Law School, where she served as the executive articles editor of the George Washington International Law Review. Rachel received her B.A. in English and legal studies from Northwestern University.
Rachel is fluent in Korean.Show More